5 Top Apps for Diabetes Caregivers
ShugaTrak, Glucose Buddy, OnTrack -- 3 of the 5 apps we highlight that are designed to make diabetes monitoring seamless for all.
True or False: Diabetes, Anxiety, and Depression
What's true and what's false about the connections between these often comorbid conditions? These 10 statements will test what you know.
5 New Diabetes Technologies for Patient Empowerment
Five slides, 5 snapshots of products that help reduce fingerstick anxiety, enhance medication adherence, and prevent plantar ulcers.
AACE/ACE Focus on Lipids: 2017 Consensus Guidelines
The AACE/ACE 2017 recommendations on lipid management renew focus on LDL-C targets, and go far lower than any group has ventured to date.
SGLT2 Inhibitor Offers CV, Renal Protection in High-risk Patients
Significant reductions were seen in MACE, renal disease progression in patients with high CV risk taking canagliflozin.
True or False: Diabetes Stats 2017
Can you sort out diabetes facts from fiction? The latest diabetes statistics from the CDC may surprise you.
T2D Study Guide, October: SGLT2 Inhibitors, GLP-1 Agonists, CV Outcomes
At-a-glance: SGLT2 inhibitors, GLP-1 agonists, insulin vs insulin, and more—a look at what’s new, what’s next.
Impact of Ethnicity, Gender on Skin Autoflourescence and Risk for CV, DM
A new study evaluates the impact of ethnicity on skin autoflourescence used to measure accumulation of atherogenic glycated proteins.
Early Respiratory Infections and Risk for Type 1 Diabetes: The TEDDY Study
Timing appears to be nearly everything when it comes to the impact of respiratory infection on autoantibody seroconversion in infants at risk for tpye 1 diabetes.
Interesting Endo: AFib, Bone Health, and Obesity
At-a-Glance: Studies you may find of interest look at AFib in T1DM, new fracture risk data, obesity outcomes, and more.